CN Patent

CN103159680A — 咪唑二酮类化合物及其用途

Assigned to AMYNIDY PHARMACEUTICAL Co Ltd · Expires 2013-06-19 · 13y expired

What this patent protects

本发明涉及一类咪唑二酮类化合物及其用途。具体地，本发明公开了一类咪唑二酮类化合物，及其药物组合物。还公开了咪唑二酮类化合物作为雄性激素受体拮抗剂，或用于治疗和预防雄性激素受体相关的疾病和失调如前列腺癌，青春痘，脱发等。

USPTO Abstract

本发明涉及一类咪唑二酮类化合物及其用途。具体地，本发明公开了一类咪唑二酮类化合物，及其药物组合物。还公开了咪唑二酮类化合物作为雄性激素受体拮抗剂，或用于治疗和预防雄性激素受体相关的疾病和失调如前列腺癌，青春痘，脱发等。

Drugs covered by this patent

Patent Metadata

Patent number
CN103159680A
Jurisdiction
CN
Classification
—
Expires
2013-06-19
Drug substance claim
No
Drug product claim
No
Assignee
AMYNIDY PHARMACEUTICAL Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.